Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News GeneDx Holdings Corp WGS

GeneDx Holdings Corp. is a genomics company. The Company is focused on delivering personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The Company's segments are GeneDx inclusive of Legacy GeneDx and Legacy Sema4. The GeneDx segment primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing... see more

Recent & Breaking News (NDAQ:WGS)

FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Sema4 Holdings Corp. - SMFR

PR Newswire October 19, 2022

DEADLINE ALERT: Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 7, 2022 in Sema4 Holdings Corp. Lawsuit - SMFR

Newsfile October 19, 2022

Sema4 Deadline Alert

Newsfile October 19, 2022

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Sema4 Holdings Corp. with Losses of $100,000 to Contact the Firm

Newsfile October 19, 2022

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Sema4 Holdings (SMFR) Investors with Significant Losses to Contact Firm's Attorneys, Deadline Approaching in Securities Fraud Class Action

Newsfile October 19, 2022

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Sema4 Holdings, Corp. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 7, 2022 - (NASDAQ: SMFR)

PR Newswire October 19, 2022

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sema4 Holdings Corp. - SMFR; SMFRW

PR Newswire October 19, 2022

DEADLINE ALERT: Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 7, 2022 in Sema4 Holdings Corp. Lawsuit - SMFR

Newsfile October 18, 2022

ROSEN, Top Ranked Investor Counsel, Encourages Sema4 Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SMFR, SMFRW

Newsfile October 18, 2022

ROSEN, A LEADING LAW FIRM, Encourages Sema4 Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SMFR, SMFRW

PR Newswire October 17, 2022

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Sema4 Holdings Corp. with Losses of $100,000 to Contact the Firm

Newsfile October 17, 2022

Sema4 Holdings Corp. Class Action: Levi & Korsinsky Reminds Sema4 Holdings, Corp. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 7, 2022 - SMFR

Newsfile October 16, 2022

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sema4 Holdings Corp. - SMFR; SMFRW

Newsfile October 16, 2022

Sema4 Deadline Alert

Newsfile October 16, 2022

SEMA4 HOLDINGS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Sema4 Holdings Corp. - SMFR

PR Newswire October 14, 2022

SMFR SHAREHOLDER ALERT: Jakubowitz Law Reminds Sema4 Holdings Corp. Shareholders of a Lead Plaintiff Deadline of November 7, 2022

PR Newswire October 14, 2022

DEADLINE ALERT: Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 7, 2022 in Sema4 Holdings Corp. Lawsuit - SMFR

Newsfile October 13, 2022

Sema4 Deadline Alert

Newsfile October 13, 2022

Study Demonstrates the Utility of Exome Sequencing for Diagnosing Autism Spectrum Disorders

GlobeNewswire October 13, 2022

SMFR LAWSUIT ALERT: Levi & Korsinsky Notifies Sema4 Holdings, Corp. Investors of a Class Action Lawsuit and Upcoming Deadline

PR Newswire October 13, 2022